The hollow-fiber bioreactors market size has grown strongly in recent years. It will grow from $1.5 billion in 2025 to $1.64 billion in 2026 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to reliance on traditional cell culture systems, limited bioreactor scalability, growing biopharmaceutical R&D activities, increasing academic research in tissue engineering, adoption of reusable bioreactors in early-stage production.
The hollow-fiber bioreactors market size is expected to see strong growth in the next few years. It will grow to $2.33 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to technological advancements in single-use bioreactors, expansion of modular and automated systems, rising demand for high-throughput protein production, increasing contract research organization (CRO) outsourcing, integration with continuous perfusion and monitoring systems. Major trends in the forecast period include increasing adoption of single-use hollow-fiber bioreactors, growth in high-density cell culture applications, rising demand for biopharmaceutical protein production, expansion of tissue engineering and regenerative medicine, focus on automated and high-throughput bioreactor systems.
The rising demand for cell-based therapy production is expected to drive growth in the hollow-fiber bioreactors market in the coming years. Cell-based therapy production involves manufacturing therapeutic products derived from living cells to treat diseases such as cancers, autoimmune disorders, and genetic conditions. The market demand is growing due to the need for scalable, high-yield, and consistent manufacturing platforms that maintain product quality even at high cell densities. Hollow-fiber bioreactors facilitate this process by providing a closed system with high surface area, enabling efficient expansion and harvesting of therapeutic cells under tightly controlled conditions. For example, in December 2024, the International Federation of Pharmaceutical Manufacturers and Associations reported that six first-in-class cell and gene therapies were introduced in 2023, a 50% increase from three in 2022, underscoring the growing need for efficient production platforms.
The increasing prevalence of personalized medicine is another key driver for the hollow-fiber bioreactors market. Personalized medicine customizes treatment based on a patient’s unique genetic profile, biology, and health needs. The rise of personalized medicine is fueled by advanced diagnostic technologies that allow precise identification of patient-specific disease mechanisms, improving treatment outcomes and minimizing trial-and-error approaches. Hollow-fiber bioreactors support this trend by enabling high-quality, scalable cell culture production for patient-specific therapies. For instance, in February 2024, the Personalized Medicine Coalition reported that the FDA approved 16 new personalized treatments for rare disease patients in 2023, up from six in 2022, highlighting the growing demand for flexible and efficient cell production systems.
Major companies operating in the hollow-fiber bioreactors market are increasingly concentrating on the development of innovative solutions, such as single-use hollow-fiber membrane networks, to support high-density, scalable, and low-shear cell culture for advanced therapeutic applications. Single-use hollow-fiber membrane networks are disposable bioreactor systems consisting of semi-permeable fibers that enable continuous nutrient supply and waste removal, helping maintain uniform nutrient distribution, low-shear conditions, and scalable high-density cell growth, while also reducing contamination risk and simplifying biomanufacturing processes. For example, in March 2025, ABEC Inc., a US-based process-engineering company, introduced its ATB (Advanced Therapy Bioreactor), a single-use, closed, hollow-fiber bioreactor platform specifically developed for advanced therapy medicinal product (ATMP) manufacturing. The ATB system incorporates proprietary hollow-fiber membrane networks that replicate the human circulatory system to provide localized nutrient and gas exchange, combined with oscillation-based mixing rather than mechanical agitation to maintain optimal cell growth conditions. The design enables consistent scale-up from 0.2 L to 10 L while maintaining the same hollow-fiber surface-area-to-volume ratio across scales, and has demonstrated high cell densities and viabilities across a variety of challenging cell types, including primary T-cells, CD34+ stem cells, HEK293, and CHO cell lines.
Major companies operating in the hollow-fiber bioreactors market are General Electric Company, Veolia Environnement S.A., Thermo Fisher Scientific Inc., Mitsubishi Chemical Corporation, Kubota Corporation, DuPont de Nemours Inc., MANN+HUMMEL GmbH, Alfa Laval AB, Sartorius AG, Repligen Corporation, Shenzhen Dreamemway Environmental Products Co. Ltd., FiberCell Systems Inc., Reynolds Culligan Water, Shanghai MegaVision Membrane Engineering & Technology Co. Ltd., Memfill Tech Private Limited, FibraCast Inc., iMemFlo Membrane Technology Co. Ltd., Guangdong Skyview Environmental Science and Technology Co. Ltd., PHILOS Co. Ltd., Blufox Engineering Pvt. Ltd.
North America was the largest region in the hollow-fiber bioreactors market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hollow-fiber bioreactors market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the hollow-fiber bioreactors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the hollow-fiber bioreactors market by increasing the cost of imported fibers, membranes, and assembly components used in both single-use and reusable bioreactors. Segments such as automated and high-capacity bioreactors are most impacted, with regions like North America and Asia-Pacific facing higher import duties. This has led to elevated production costs and delays in supply chains. Positively, tariffs have encouraged local manufacturing, development of alternative sourcing strategies, and investment in domestic production infrastructure.
The hollow-fiber bioreactors market research report is one of a series of new reports that provides hollow-fiber bioreactors market statistics, including hollow-fiber bioreactors industry global market size, regional shares, competitors with a hollow-fiber bioreactors market share, detailed hollow-fiber bioreactors market segments, market trends and opportunities, and any further data you may need to thrive in the hollow-fiber bioreactors industry. This hollow-fiber bioreactors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Hollow-fiber bioreactors are sophisticated cell culture systems that utilize bundles of semi-permeable hollow fibers to provide a high surface area environment for cell growth and product synthesis. These bioreactors facilitate efficient nutrient, gas, and waste exchange, closely replicating physiological conditions. They are widely employed for high-density cell culture, protein production, and continuous perfusion processes in both biomanufacturing and research settings.
The primary product categories of hollow-fiber bioreactors include single-use and reusable systems. Single-use hollow-fiber bioreactors are designed for one-time applications, featuring pre-sterilized components that minimize the need for extensive cleaning and preparation between production cycles. They find application in cell culture, tissue engineering, biopharmaceutical production, wastewater treatment, and more, and are utilized by various end-users such as pharmaceutical and biotechnology companies, research institutions, and contract research organizations.
The hollow-fiber bioreactors market consists of sales of membrane-based hollow-fiber bioreactors, perfusion hollow-fiber bioreactors, high-density hollow-fiber bioreactors, oxygen-permeable hollow-fiber bioreactors, and modular hollow-fiber bioreactors. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The hollow-fiber bioreactors market size is expected to see strong growth in the next few years. It will grow to $2.33 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to technological advancements in single-use bioreactors, expansion of modular and automated systems, rising demand for high-throughput protein production, increasing contract research organization (CRO) outsourcing, integration with continuous perfusion and monitoring systems. Major trends in the forecast period include increasing adoption of single-use hollow-fiber bioreactors, growth in high-density cell culture applications, rising demand for biopharmaceutical protein production, expansion of tissue engineering and regenerative medicine, focus on automated and high-throughput bioreactor systems.
The rising demand for cell-based therapy production is expected to drive growth in the hollow-fiber bioreactors market in the coming years. Cell-based therapy production involves manufacturing therapeutic products derived from living cells to treat diseases such as cancers, autoimmune disorders, and genetic conditions. The market demand is growing due to the need for scalable, high-yield, and consistent manufacturing platforms that maintain product quality even at high cell densities. Hollow-fiber bioreactors facilitate this process by providing a closed system with high surface area, enabling efficient expansion and harvesting of therapeutic cells under tightly controlled conditions. For example, in December 2024, the International Federation of Pharmaceutical Manufacturers and Associations reported that six first-in-class cell and gene therapies were introduced in 2023, a 50% increase from three in 2022, underscoring the growing need for efficient production platforms.
The increasing prevalence of personalized medicine is another key driver for the hollow-fiber bioreactors market. Personalized medicine customizes treatment based on a patient’s unique genetic profile, biology, and health needs. The rise of personalized medicine is fueled by advanced diagnostic technologies that allow precise identification of patient-specific disease mechanisms, improving treatment outcomes and minimizing trial-and-error approaches. Hollow-fiber bioreactors support this trend by enabling high-quality, scalable cell culture production for patient-specific therapies. For instance, in February 2024, the Personalized Medicine Coalition reported that the FDA approved 16 new personalized treatments for rare disease patients in 2023, up from six in 2022, highlighting the growing demand for flexible and efficient cell production systems.
Major companies operating in the hollow-fiber bioreactors market are increasingly concentrating on the development of innovative solutions, such as single-use hollow-fiber membrane networks, to support high-density, scalable, and low-shear cell culture for advanced therapeutic applications. Single-use hollow-fiber membrane networks are disposable bioreactor systems consisting of semi-permeable fibers that enable continuous nutrient supply and waste removal, helping maintain uniform nutrient distribution, low-shear conditions, and scalable high-density cell growth, while also reducing contamination risk and simplifying biomanufacturing processes. For example, in March 2025, ABEC Inc., a US-based process-engineering company, introduced its ATB (Advanced Therapy Bioreactor), a single-use, closed, hollow-fiber bioreactor platform specifically developed for advanced therapy medicinal product (ATMP) manufacturing. The ATB system incorporates proprietary hollow-fiber membrane networks that replicate the human circulatory system to provide localized nutrient and gas exchange, combined with oscillation-based mixing rather than mechanical agitation to maintain optimal cell growth conditions. The design enables consistent scale-up from 0.2 L to 10 L while maintaining the same hollow-fiber surface-area-to-volume ratio across scales, and has demonstrated high cell densities and viabilities across a variety of challenging cell types, including primary T-cells, CD34+ stem cells, HEK293, and CHO cell lines.
Major companies operating in the hollow-fiber bioreactors market are General Electric Company, Veolia Environnement S.A., Thermo Fisher Scientific Inc., Mitsubishi Chemical Corporation, Kubota Corporation, DuPont de Nemours Inc., MANN+HUMMEL GmbH, Alfa Laval AB, Sartorius AG, Repligen Corporation, Shenzhen Dreamemway Environmental Products Co. Ltd., FiberCell Systems Inc., Reynolds Culligan Water, Shanghai MegaVision Membrane Engineering & Technology Co. Ltd., Memfill Tech Private Limited, FibraCast Inc., iMemFlo Membrane Technology Co. Ltd., Guangdong Skyview Environmental Science and Technology Co. Ltd., PHILOS Co. Ltd., Blufox Engineering Pvt. Ltd.
North America was the largest region in the hollow-fiber bioreactors market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hollow-fiber bioreactors market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the hollow-fiber bioreactors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the hollow-fiber bioreactors market by increasing the cost of imported fibers, membranes, and assembly components used in both single-use and reusable bioreactors. Segments such as automated and high-capacity bioreactors are most impacted, with regions like North America and Asia-Pacific facing higher import duties. This has led to elevated production costs and delays in supply chains. Positively, tariffs have encouraged local manufacturing, development of alternative sourcing strategies, and investment in domestic production infrastructure.
The hollow-fiber bioreactors market research report is one of a series of new reports that provides hollow-fiber bioreactors market statistics, including hollow-fiber bioreactors industry global market size, regional shares, competitors with a hollow-fiber bioreactors market share, detailed hollow-fiber bioreactors market segments, market trends and opportunities, and any further data you may need to thrive in the hollow-fiber bioreactors industry. This hollow-fiber bioreactors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Hollow-fiber bioreactors are sophisticated cell culture systems that utilize bundles of semi-permeable hollow fibers to provide a high surface area environment for cell growth and product synthesis. These bioreactors facilitate efficient nutrient, gas, and waste exchange, closely replicating physiological conditions. They are widely employed for high-density cell culture, protein production, and continuous perfusion processes in both biomanufacturing and research settings.
The primary product categories of hollow-fiber bioreactors include single-use and reusable systems. Single-use hollow-fiber bioreactors are designed for one-time applications, featuring pre-sterilized components that minimize the need for extensive cleaning and preparation between production cycles. They find application in cell culture, tissue engineering, biopharmaceutical production, wastewater treatment, and more, and are utilized by various end-users such as pharmaceutical and biotechnology companies, research institutions, and contract research organizations.
The hollow-fiber bioreactors market consists of sales of membrane-based hollow-fiber bioreactors, perfusion hollow-fiber bioreactors, high-density hollow-fiber bioreactors, oxygen-permeable hollow-fiber bioreactors, and modular hollow-fiber bioreactors. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Hollow-Fiber Bioreactors Market Characteristics
3. Hollow-Fiber Bioreactors Market Supply Chain Analysis
4. Global Hollow-Fiber Bioreactors Market Trends and Strategies
5. Hollow-Fiber Bioreactors Market Analysis of End Use Industries
7. Global Hollow-Fiber Bioreactors Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Hollow-Fiber Bioreactors Total Addressable Market (TAM) Analysis for the Market
9. Hollow-Fiber Bioreactors Market Segmentation
10. Hollow-Fiber Bioreactors Market Regional and Country Analysis
11. Asia-Pacific Hollow-Fiber Bioreactors Market
12. China Hollow-Fiber Bioreactors Market
13. India Hollow-Fiber Bioreactors Market
14. Japan Hollow-Fiber Bioreactors Market
15. Australia Hollow-Fiber Bioreactors Market
16. Indonesia Hollow-Fiber Bioreactors Market
17. South Korea Hollow-Fiber Bioreactors Market
18. Taiwan Hollow-Fiber Bioreactors Market
19. South East Asia Hollow-Fiber Bioreactors Market
20. Western Europe Hollow-Fiber Bioreactors Market
21. UK Hollow-Fiber Bioreactors Market
22. Germany Hollow-Fiber Bioreactors Market
23. France Hollow-Fiber Bioreactors Market
24. Italy Hollow-Fiber Bioreactors Market
25. Spain Hollow-Fiber Bioreactors Market
26. Eastern Europe Hollow-Fiber Bioreactors Market
27. Russia Hollow-Fiber Bioreactors Market
28. North America Hollow-Fiber Bioreactors Market
29. USA Hollow-Fiber Bioreactors Market
30. Canada Hollow-Fiber Bioreactors Market
31. South America Hollow-Fiber Bioreactors Market
32. Brazil Hollow-Fiber Bioreactors Market
33. Middle East Hollow-Fiber Bioreactors Market
34. Africa Hollow-Fiber Bioreactors Market
36. Hollow-Fiber Bioreactors Market Competitive Landscape and Company Profiles
37. Hollow-Fiber Bioreactors Market Other Major and Innovative Companies
40. Hollow-Fiber Bioreactors Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Hollow-Fiber Bioreactors Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses hollow-fiber bioreactors market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for hollow-fiber bioreactors? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hollow-fiber bioreactors market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Single-Use Hollow-Fiber Bioreactors; Reusable Hollow-Fiber Bioreactors2) By Application: Cell Culture; Tissue Engineering; Biopharmaceutical Production; Wastewater Treatment; Other Applications
3) By End-User: Pharmaceutical And Biotechnology Companies; Research Institutes; Contract Research Organizations; Other End-Users
Subsegments:
1) By Single-Use Hollow-Fiber Bioreactors: Pre-Assembled Single-Use Hollow-Fiber Bioreactors; Modular Single-Use Hollow-Fiber Bioreactors; Customizable Single-Use Hollow-Fiber Bioreactors; High-Throughput Single-Use Hollow-Fiber Bioreactors; Automated Single-Use Hollow-Fiber Bioreactors2) By Reusable Hollow-Fiber Bioreactors: Fixed-Bed Reusable Hollow-Fiber Bioreactors; Modular Reusable Hollow-Fiber Bioreactors; High-Capacity Reusable Hollow-Fiber Bioreactors; Multipurpose Reusable Hollow-Fiber Bioreactors; Clean-In-Place Reusable Hollow-Fiber Bioreactors
Companies Mentioned: General Electric Company; Veolia Environnement S.A.; Thermo Fisher Scientific Inc.; Mitsubishi Chemical Corporation; Kubota Corporation; DuPont de Nemours Inc.; MANN+HUMMEL GmbH; Alfa Laval AB; Sartorius AG; Repligen Corporation; Shenzhen Dreamemway Environmental Products Co. Ltd.; FiberCell Systems Inc.; Reynolds Culligan Water; Shanghai MegaVision Membrane Engineering & Technology Co. Ltd.; Memfill Tech Private Limited; FibraCast Inc.; iMemFlo Membrane Technology Co. Ltd.; Guangdong Skyview Environmental Science and Technology Co. Ltd.; PHILOS Co. Ltd.; Blufox Engineering Pvt. Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Hollow-Fiber Bioreactors market report include:- General Electric Company
- Veolia Environnement S.A.
- Thermo Fisher Scientific Inc.
- Mitsubishi Chemical Corporation
- Kubota Corporation
- DuPont de Nemours Inc.
- MANN+HUMMEL GmbH
- Alfa Laval AB
- Sartorius AG
- Repligen Corporation
- Shenzhen Dreamemway Environmental Products Co. Ltd.
- FiberCell Systems Inc.
- Reynolds Culligan Water
- Shanghai MegaVision Membrane Engineering & Technology Co. Ltd.
- Memfill Tech Private Limited
- FibraCast Inc.
- iMemFlo Membrane Technology Co. Ltd.
- Guangdong Skyview Environmental Science and Technology Co. Ltd.
- PHILOS Co. Ltd.
- Blufox Engineering Pvt. Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.64 Billion |
| Forecasted Market Value ( USD | $ 2.33 Billion |
| Compound Annual Growth Rate | 9.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
